Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5667_Библиотеки_им_академика_М_И_Перельмана
.pdf
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
186
14 Flynn, R.A., Pedram, K., Malaker, S.A. etal. (2021). Small RNAs are modified with
N‐glycans and displayed on the surface of living cells. Cell 184 (12): 3109–3124.
15 Reis, C.A., Osorio, H., Silva, L. etal. (2010). Alterations in glycosylation as
biomarkers for cancer detection. Journal of Clinical Pathology 63 (4): 322–329.
16 Marcos, N.T., Pinho, S., Grandela, C. etal. (2004). Role of the human
ST6GalNAc‐I and ST6GalNAc‐II in the synthesis of the cancer‐associated sialyl‐Tn
antigen. Cancer Research 64 (19): 7050–7057.
17 Warnock, M., Stoloff, A., and Thor, A. (1988). Differentiation of adenocarcinoma
of the lung from mesothelioma. Periodic acid‐Schiff, monoclonal antibodies
B72.3, and Leu M1. The American Journal of Pathology 133 (1): 30.
18 O’Boyle, K.P., Markowitz, A.L., Khorshidi, M. etal. (1996). Specificity analysis of
murine monoclonal antibodies reactive with Tn, sialylated Tn, T, and
monosialylated (2 → 6) T antigens. Hybridoma 15 (6): 401–408.
19 Köhler, G. and Milstein, C. (1975). Continuous cultures of fused cells secreting
antibody of predefined specificity. Nature 256 (5517): 495–497.
20 Cummings, R.D. (2009). The repertoire of glycan determinants in the human
glycome. Molecular BioSystems 5 (10): 1087–1104.
21 Briard, J.G., Jiang, H., Moremen, K.W. etal. (2018). Cell‐based glycan arrays for
probing glycan–glycan binding protein interactions. Nature Communications 9
(1): 1–11.
22 Blaschke, C.R.K., McDowell, C.T., Black, A.P. etal. (2021). Glycan imaging mass
spectrometry: progress in developing clinical diagnostic assays for tissues,
biofluids, and cells. Clinics in Laboratory Medicine 41 (2): 247–266.
23 Powers, T.W., Neely, B.A., Shao, Y. etal. (2014). MALDI imaging mass
spectrometry profiling of N‐glycans in formalin‐fixed paraffin embedded clinical
tissue blocks and tissue microarrays. PLoS One 9 (9): e106255.
24 Everest‐Dass, A.V., Briggs, M.T., Kaur, G. etal. (2016). N‐glycan MALDI imaging
mass spectrometry on formalin‐fixed paraffin‐embedded tissue enables the
delineation of ovarian cancer tissues. Molecular and Cellular Proteomics 15 (9):
3003–3016.
25 Kunzke, T., Balluff, B., Feuchtinger, A. etal. (2017). Native glycan fragments
detected by MALDI‐FT‐ICR mass spectrometry imaging impact gastric cancer
biology and patient outcome. Oncotarget 8 (40): 68012.
26 Briggs, M.T., Condina, M.R., Ho, Y.Y. etal. (2019). MALDI mass spectrometry
imaging of early‐and late‐stage serous ovarian cancer tissue reveals stage‐specific
N‐glycans. Proteomics 19 (21, 22): 1800482.
27 Heijs, B., Holst‐Bernal, S., de Graaff, M.A. etal. (2020). Molecular signatures of
tumor progression in myxoid liposarcoma identified by N‐glycan mass
spectrometry imaging. Laboratory Investigation 100 (9): 1252–1261.
28 Boyaval, F., Van Zeijl, R., Dalebout, H. etal. (2021). N‐glycomic signature of stage
II colorectal cancer and its association with the tumor microenvironment.
Molecular and Cellular Proteomics 20: 100057.
29 Holst, S., Heijs, B., De Haan, N. etal. (2016). Linkage‐specific in situ sialic acid
derivatization for N‐glycan mass spectrometry imaging of formalin‐fixed paraffin‐
embedded tissues. Analytical Chemistry 88 (11): 5904–5913.
30 Norris, J.L., Porter, N.A., and Caprioli, R.M. (2005). Combination detergent/
MALDI matrix: functional cleavable detergents for mass spectrometry. Analytical
Chemistry 77 (15): 5036–5040.
31 Lemaire, R., Tabet, J., Ducoroy, P. etal. (2006). Solid ionic matrixes for direct
tissue analysis and MALDI imaging. Analytical Chemistry 78 (3): 809–819.
32 Zhang, H., Shi, X., Vu, N.Q. etal. (2020). On‐tissue derivatization with Girard’s
reagent P enhances N‐glycan signals for formalin‐fixed paraffin‐embedded tissue
sections in MALDI mass spectrometry imaging. Analytical Chemistry 92 (19):
13361–13368.
33 Arentz, G., Mittal, P., Zhang, C. etal. (2017). Applications of mass spectrometry
34 Powers, T.W., Jones, E.E., Betesh, L.R. etal. (2013). Matrix assisted laser
desorption ionization imaging mass spectrometry workflow for spatial profiling
analysis of N‐linked glycan expression in tissues. Analytical Chemistry 85 (20):
9799–9806.
35 Powers, T.W., Holst, S., Wuhrer, M. etal. (2015). Two‐dimensional N‐glycan
distribution mapping of hepatocellular carcinoma tissues by MALDI‐imaging
mass spectrometry. Biomolecules 5 (4): 2554–2572.
36 Drake, R.R., Powers, T.W., Norris‐Caneda, K. etal. (2018). In situ imaging of
N‐glycans by MALDI imaging mass spectrometry of fresh or formalin‐fixed
paraffin‐embedded tissue. Current Protocols in Protein Science 94 (1): e68.
37 Drake, R.R., Powers, T.W., Jones, E.E. etal. (2017). MALDI mass spectrometry
imaging of N‐linked glycans in cancer tissues. Advances in Cancer Research
134: 85–116.
38 Heijs, B., Holst, S., Briaire‐de Bruijn, I.H. etal. (2016). Multimodal mass
spectrometry imaging of N‐glycans and proteins from the same tissue section.
Analytical Chemistry 88 (15): 7745–7753.
39 Fredriksson, S., Gullberg, M., Jarvius, J. etal. (2002). Protein detection using
proximity‐dependent DNA ligation assays. Nature Biotechnology 20 (5): 473–477.
40 Oliveira, F.M.S., Mereiter, S., Lönn, P. etal. (2018). Detection of post‐translational
modifications using solid‐phase proximity ligation assay. New Biotechnology
45: 51–59.
41 Söderberg, O., Leuchowius, K.‐J., Gullberg, M. etal. (2008). Characterizing
proteins and their interactions in cells and tissues using the in situ proximity
ligation assay. Methods 45 (3): 227–232.
42 Pinto, R., Carvalho, A.S., Conze, T. etal. (2012). Identification of new cancer
biomarkers based on aberrant mucin glycoforms by in situ proximity ligation.
Journal of Cellular and Molecular Medicine 16 (7): 1474–1484.
43 Campos, D., Freitas, D., Gomes, J. etal. (2015). Probing the O‐glycoproteome of
gastric cancer cell lines for biomarker discovery. Molecular and Cellular
Proteomics 14 (6): 1616–1629.
44 Mereiter, S., Martins, Á.M., Gomes, C. etal. (2019). O‐glycan truncation enhances
cancer‐related functions of CD44in gastric cancer. FEBS Letters 593 (13):
1675–1689.
187
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
188
45 Mereiter, S., Magalhães, A., Adamczyk, B. etal. (2016). Glycomic analysis of
gastric carcinoma cells discloses glycans as modulators of RON receptor tyrosine
kinase activation in cancer. Biochimica et Biophysica Acta (BBA), General Subjects
1860 (8): 1795–1808.
46 Gomes, C., Almeida, A., Barreira, A. etal. (2019). Carcinoembryonic antigen
carrying SLe(X) as a new biomarker of more aggressive gastric carcinomas.
Theranostics 9 (24): 7431–7446.
47 Carvalho, S., Catarino, T.A., Dias, A.M. etal. (2016). Preventing E‐cadherin
aberrant N‐glycosylation at Asn‐554 improves its critical function in gastric
cancer. Oncogene 35 (13): 1619–1631.
48 Duarte, H.O., Rodrigues, J.G., Gomes, C. etal. (2021). ST6Gal1 targets the
ectodomain of ErbB2in a site‐specific manner and regulates gastric cancer cell
sensitivity to trastuzumab. Oncogene 40 (21): 3719–3733.
49 Magalhães, A., Rossez, Y., Robbe‐Masselot, C. etal. (2016). Muc5ac gastric mucin
glycosylation is shaped by FUT2 activity and functionally impacts Helicobacter
pylori binding. Scientific Reports 6 (1): 25575.
50 Li, X., Jiang, X., Xu, X. etal. (2017). Imaging of protein‐specific glycosylation by
glycan metabolic tagging and in situ proximity ligation. Carbohydrate Research
448: 148–154.
51 Freeze, H.H. (2006). Genetic defects in the human glycome. Nature Reviews
Genetics 7 (7): 537–551.
52 Wang, D., Liu, S., Trummer, B.J. etal. (2002). Carbohydrate microarrays for the
recognition of cross‐reactive molecular markers of microbes and host cells. Nature
Biotechnology 20 (3): 275–281.
53 Fukui, S., Feizi, T., Galustian, C. etal. (2002). Oligosaccharide microarrays for
high‐throughput detection and specificity assignments of carbohydrate‐protein
interactions. Nature Biotechnology 20 (10): 1011–1017.
54 Gao, C., Wei, M., McKitrick, T.R. etal. (2019). Glycan microarrays as chemical
tools for identifying glycan recognition by immune proteins. Frontiers in
Chemistry 7 (833): 833.
55 Song, X., Heimburg‐Molinaro, J., Cummings, R.D., and Smith, D.F. (2014).
Chemistry of natural glycan microarrays. Current Opinion in Chemical Biology
18: 70–77.
56 Hirabayashi, J., Yamada, M., Kuno, A., and Tateno, H. (2013). Lectin microarrays:
concept, principle and applications. Chemical Society Reviews 42 (10): 4443–4458.
57 Li, Z. and Feizi, T. (2018). The neoglycolipid (NGL) technology‐based microarrays
and future prospects. FEBS Letters 592 (23): 3976–3991.
58 Smith, D.F., Song, X., and Cummings, R.D. (2010). Chapter Nineteen– Use of
glycan microarrays to explore specificity of glycan‐binding proteins. In: Methods
in Enzymology, vol. 480 (ed. M. Fukuda), 417–444. Academic Press.
59 Drickamer, K. and Taylor, M.E. (2002). Glycan arrays for functional glycomics.
Genome Biology 3 (12): reviews1034.1.
60 Patwa, T., Li, C., Simeone, D.M., and Lubman, D.M. (2010). Glycoprotein analysis
using protein microarrays and mass spectrometry. Mass Spectrometry Reviews 29
(5): 830–844.
61 Tse‐Wen, C. (1983). Binding of cells to matrixes of distinct antibodies coated on
solid surface. Journal of Immunological Methods 65 (1): 217–223.
62 Song, X., Heimburg‐Molinaro, J., Smith, D.F., and Cummings, R.D. (2015). Glycan
microarrays of fluorescently‐tagged natural glycans. Glycoconjugate Journal 32 (7):
465–473.
63 Palma, A.S., Feizi, T., Zhang, Y. etal. (2006). Ligands for the β‐glucan receptor,
dectin‐1, assigned using “designer” microarrays of oligosaccharide probes
(neoglycolipids) generated from glucan polysaccharides. Journal of Biological
Chemistry 281 (9): 5771–5779.
64 Liu, L., Prudden, A.R., Capicciotti, C.J. etal. (2019). Streamlining the
chemoenzymatic synthesis of complex N‐glycans by a stop and go strategy. Nature
Chemistry 11 (2): 161–169.
65 Fair, R.J., Hahm, H.S., and Seeberger, P.H. (2015). Combination of automated
solid‐phase and enzymatic oligosaccharide synthesis provides access to α(2,3)‐
sialylated glycans. Chemical Communications 51 (28): 6183–6185.
66 Esposito, D., Hurevich, M., Castagner, B. etal. (2012). Automated synthesis of
sialylated oligosaccharides. Beilstein Journal of Organic Chemistry 8: 1601–1609.
67 Li, T., Liu, L., Wei, N. etal. (2019). An automated platform for the enzyme‐
mediated assembly of complex oligosaccharides. Nature Chemistry 11 (3):
229–236.
68 Liang, C.F., Hahm, H.S., and Seeberger, P.H. (2015). Automated synthesis of
chondroitin sulfate oligosaccharides. Methods in Molecular Biology 1229: 3–10.
69 Song, X., Xia, B., Stowell, S.R. etal. (2009). Novel fluorescent glycan microarray
strategy reveals ligands for galectins. Chemistry and Biology 16 (1): 36–47.
70 Xia, B., Kawar, Z.S., Ju, T. etal. (2005). Versatile fluorescent derivatization of
glycans for glycomic analysis. Nature Methods 2 (11): 845–850.
71 de Boer, A.R., Hokke, C.H., Deelder, A.M., and Wuhrer, M. (2007). General
microarray technique for immobilization and screening of natural glycans.
Analytical Chemistry 79 (21): 8107–8113.
72 McQuillan, A.M., Byrd‐Leotis, L., Heimburg‐Molinaro, J., and Cummings,
R.D. (2019). Natural and synthetic sialylated glycan microarrays and their
applications. Frontiers in Molecular Biosciences 6: 88.
73 Temme, J.S., Campbell, C.T., and Gildersleeve, J.C. (2019). Factors contributing to
variability of glycan microarray binding profiles. Faraday Discussions 219: 90–111.
74 Wang, R., Liu, S., Shah, D., and Wang, D. (2005). A practical protocol for
carbohydrate microarrays. In: Chemical Genomics: Reviews and Protocols (ed.
E.D. Zanders), 241–252. Totowa, NJ: Humana Press.
75 Wang, C.‐C., Huang, Y.‐L., Ren, C.‐T. etal. (2008). Glycan microarray of Globo H
and related structures for quantitative analysis of breast cancer. Proceedings of the
National Academy of Sciences of the United States of America 105 (33):
11661–11666.
76 Gao, C., Liu, Y., Zhang, H. etal. (2014). Carbohydrate sequence of the prostate
cancer‐associated antigen F77 assigned by a Mucin O‐glycome designer array.
Journal of Biological Chemistry 289 (23): 16462–16477.
189
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
190
77 Blixt, O., Head, S., Mondala, T. etal. (2004). Printed covalent glycan array for
ligand profiling of diverse glycan binding proteins. Proceedings of the National
Academy of Sciences of the United States of America 101 (49): 17033–17038.
78 Song, X., Xia, B., Lasanajak, Y. etal. (2008). Quantifiable fluorescent glycan
microarrays. Glycoconjugate Journal 25 (1): 15–25.
79 Chen, S., LaRoche, T., Hamelinck, D. etal. (2007). Multiplexed analysis of glycan
variation on native proteins captured by antibody microarrays. Nature Methods 4
(5): 437–444.
80 Park, H., Jung, J., Rodrigues, E. etal. (2020). Mass spectrometry‐based shotgun
glycomics for discovery of natural ligands of glycan‐binding proteins. Analytical
Chemistry 92 (20): 14012–14020.
81 Padler‐Karavani, V., Song, X., Yu, H. etal. (2012). Cross‐comparison of protein
recognition of sialic acid diversity on two novel sialoglycan microarrays. The
Journal of Biological Chemistry 287 (27): 22593–22608.
82 Büll, C., Nason, R., Sun, L. etal. (2021). Probing the binding specificities of
human Siglecs by cell‐based glycan arrays. Proceedings of the National Academy of
Sciences of the United States of America 118 (17): e2026102118.
83 Wang, S., Chen, C., Guan, M. etal. (2021). Terminal epitope‐dependent branch
preference of siglecs toward N‐glycans. Frontiers in Molecular Biosciences 8
(142): 645999.
84 Arthur, C.M., Rodrigues, L.C., Baruffi, M.D. etal. (2015). Examining galectin
binding specificity using glycan microarrays. Methods in Molecular Biology
(Clifton, N.J.) 1207: 115–131.
85 Padler‐Karavani, V., Hurtado‐Ziola, N., Pu, M. etal. (2011). Human xeno‐
autoantibodies against a non‐human sialic acid serve as novel serum biomarkers
and immunotherapeutics in cancer. Cancer Research 71 (9): 3352–3363.
86 Lawrie, C.H., Marafioti, T., Hatton, C.S.R. etal. (2006). Cancer‐associated
carbohydrate identification in Hodgkin’s lymphoma by carbohydrate array
profiling. International Journal of Cancer 118 (12): 3161–3166.
87 Huang, W.‐L., Li, Y.‐G., Lv, Y.‐C. etal. (2014). Use of lectin microarray to
differentiate gastric cancer from gastric ulcer. World Journal of Gastroenterology 20
(18): 5474–5482.
88 Purohit, S., Li, T., Guan, W. etal. (2018). Multiplex glycan bead array for high
throughput and high content analyses of glycan binding proteins. Nature
Communications 9 (1): 258.
89 Pedersen, J.W., Blixt, O., Bennett, E.P. etal. (2011). Seromic profiling of colorectal
cancer patients with novel glycopeptide microarray. International Journal of
Cancer 128 (8): 1860–1871.
90 Zhao, J., Patwa, T.H., Qiu, W. etal. (2007). Glycoprotein microarrays with
multi‐lectin detection: unique lectin binding patterns as a tool for classifying
normal, chronic pancreatitis and pancreatic cancer sera. Journal of Proteome
Research 6 (5): 1864–1874.
91 Burford, B., Gentry‐Maharaj, A., Graham, R. etal. (2013). Autoantibodies to
MUC1 glycopeptides cannot be used as a screening assay for early detection of
breast, ovarian, lung or pancreatic cancer. British Journal of Cancer 108 (10):
2045–2055.
92 Matsushita, T., Takada, W., Igarashi, K. etal. (2014). A straightforward protocol for
the preparation of high performance microarray displaying synthetic MUC1
glycopeptides. Biochimica et Biophysica Acta (BBA), General Subjects 1840 (3):
1105–1116.
93 Peng, W., Nycholat, C.M., and Razi, N. (2013). Glycan microarray screening assay
for glycosyltransferase specificities. Methods in Molecular Biology 1022: 1–14.
94 Ban, L., Pettit, N., Li, L. etal. (2012). Discovery of glycosyltransferases using
carbohydrate arrays and mass spectrometry. Nature Chemical Biology 8 (9):
769–773.
95 Muthana, S.M. (2020). Glycan microarray: toward drug discovery and
development. In: Carbohydrates in Drug Discovery and Development (ed.
V.K. Tiwari), 267–282. Elsevier.
96 Narimatsu, Y., Büll, C., Chen, Y.‐H. etal. (2021). Genetic glycoengineering in
mammalian cells. Journal of Biological Chemistry 296: 100448.
97 Chen, Y.‐H., Narimatsu, Y., Clausen, T.M. etal. (2018). The GAGOme: a cell‐based
library of displayed glycosaminoglycans. Nature Methods 15 (11): 881–888.
98 Narimatsu, Y., Joshi, H.J., Yang, Z. etal. (2018). A validated gRNA library for
CRISPR/Cas9 targeting of the human glycosyltransferase genome. Glycobiology 28
(5): 295–305.
99 Narimatsu, Y., Joshi, H.J., Nason, R. etal. (2019). An atlas of human glycosylation
pathways enables display of the human glycome by gene engineered cells.
Molecular Cell 75 (2): 394–407.e5.
100 Lonowski, L.A., Narimatsu, Y., Riaz, A. etal. (2017). Genome editing using FACS
enrichment of nuclease‐expressing cells and indel detection by amplicon analysis.
Nature Protocols 12 (3): 581–603.
101 Yang, Z., Wang, S., Halim, A. etal. (2015). Engineered CHO cells for production of
diverse, homogeneous glycoproteins. Nature Biotechnology 33 (8): 842–844.
102 Schulz, M.A., Tian, W., Mao, Y. etal. (2018). Glycoengineering design options for
IgG1in CHO cells using precise gene editing. Glycobiology 28 (7): 542–549.
103 Tian, W., Ye, Z., Wang, S. etal. (2019). The glycosylation design space for
recombinant lysosomal replacement enzymes produced in CHO cells. Nature
Communications 10 (1): 1785.
104 Čaval, T., Tian, W., Yang, Z. etal. (2018). Direct quality control of glycoengineered
erythropoietin variants. Nature Communications 9 (1): 3342.
105 Stanley, P. (2016). What have we learned from glycosyltransferase knockouts in
mice? Journal of Molecular Biology 428 (16): 3166–3182.
106 Orr, S.L., Le, D., Long, J.M. etal. (2012). A phenotype survey of 36mutant mouse
strains with gene‐targeted defects in glycosyltransferases or glycan‐binding
proteins. Glycobiology 23 (3): 363–380.
107 Takahashi, M., Yokoe, S., Asahi, M. etal. (2008). N‐glycan of ErbB family plays a
crucial role in dimer formation and tumor promotion. Biochimica et Biophysica
Acta (BBA), General Subjects 1780 (3): 520–524.
191
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
192
108 Miller, J.C., Holmes, M.C., Wang, J. etal. (2007). An improved zinc‐finger
nuclease architecture for highly specific genome editing. Nature Biotechnology 25
(7): 778–785.
109 Miller, J.C., Tan, S., Qiao, G. etal. (2011). A TALE nuclease architecture for
efficient genome editing. Nature Biotechnology 29 (2): 143–148.
110 Cong, L., Ran, F.A., Cox, D. etal. (2013). Multiplex genome engineering using
CRISPR/Cas systems. Science 339 (6121): 819–823.
111 Adli, M. (2018). The CRISPR tool kit for genome editing and beyond. Nature
Communications 9 (1): 1911.
112 Zhu, Y., Groth, T., Kelkar, A. etal. (2020). A GlycoGene CRISPR‐Cas9lentiviral
library to study lectin binding and human glycan biosynthesis pathways.
Glycobiology 31 (3): 173–180.
113 KJlC, K., Hefzi, H., Xiong, K. etal. (2020). Awakening dormant
glycosyltransferases in CHO cells with CRISPRa. Biotechnology and Bioengineering
117 (2): 593–598.
114 Schjoldager, K.T.‐B.G., Vakhrushev, S.Y., Kong, Y. etal. (2012). Probing isoform‐
specific functions of polypeptide GalNAc‐transferases using zinc finger nuclease
glycoengineered SimpleCells. Proceedings of the National Academy of Sciences of
the United States of America 109 (25): 9893–9898.
115 Hintze, J., Ye, Z., Narimatsu, Y. etal. (2018). Probing the contribution of
individual polypeptide GalNAc‐transferase isoforms to the O‐glycoproteome by
inducible expression in isogenic cell lines. Journal of Biological Chemistry 293
(49): 19064–19077.
116 Lavrsen, K., Dabelsteen, S., Vakhrushev, S.Y. etal. (2018). De novo expression of
human polypeptide N‐acetylgalactosaminyltransferase 6 (GalNAc‐T6) in colon
adenocarcinoma inhibits the differentiation of colonic epithelium. Journal of
Biological Chemistry 293 (4): 1298–1314.
117 Steentoft, C., Vakhrushev, S.Y., Joshi, H.J. etal. (2013). Precision mapping of the
human O‐GalNAc glycoproteome through SimpleCell technology. The EMBO
Journal 32 (10): 1478–1488.
118 Steentoft, C., Vakhrushev, S.Y., Vester‐Christensen, M.B. etal. (2011). Mining the
O‐glycoproteome using zinc‐finger nuclease–glycoengineered SimpleCell lines.
Nature Methods 8 (11): 977–982.
119 Vester‐Christensen, M.B., Halim, A., Joshi, H.J. etal. (2013). Mining the
O‐mannose glycoproteome reveals cadherins as major O‐mannosylated
glycoproteins. Proceedings of the National Academy of Sciences of the United States
of America 110 (52): 21018–21023.
120 Büll, C., Joshi, H.J., Clausen, H., and Narimatsu, Y. (2020). Cell‐based glycan
arrays–a practical guide to dissect the human glycome. STAR Protocols 1
(1): 100017.
121 Joeh, E., O’Leary, T., Li, W. etal. (2020). Mapping glycan‐mediated
galectin‐3interactions by live cell proximity labeling. Proceedings of the National
Academy of Sciences of the United States of America 117 (44): 27329–27338.
122 Wang, H. and Mooney, D.J. (2020). Metabolic glycan labelling for cancer‐targeted
therapy. Nature Chemistry 12 (12): 1102–1114.
123 Schumann, B., Malaker, S.A., Wisnovsky, S.P. etal. (2020). Bump‐and‐hole
engineering identifies specific substrates of glycosyltransferases in living cells.
Molecular Cell 78 (5): 824–34.e15.
124 Agatemor, C., Buettner, M.J., Ariss, R. etal. (2019). Exploiting metabolic
glycoengineering to advance healthcare. Nature Reviews Chemistry 3 (10):
605–620.
125 Debets, M.F., Tastan, O.Y., Wisnovsky, S.P. etal. (2020). Metabolic precision
labeling enables selective probing of O‐linked N‐acetylgalactosamine
glycosylation. Proceedings of the National Academy of Sciences of the United States
of America 117 (41): 25293–25301.
126 Cioce, A., Malaker, S.A., and Schumann, B. (2021). Generating orthogonal
glycosyltransferase and nucleotide sugar pairs as next‐generation glycobiology
tools. Current Opinion in Chemical Biology 60: 66–78.
127 Prescher, J.A. and Bertozzi, C.R. (2006). Chemical technologies for probing
glycans. Cell 126 (5): 851–854.
128 Thirumurugan, P., Matosiuk, D., and Jozwiak, K. (2013). Click chemistry for drug
development and diverse chemical–biology applications. Chemical Reviews 113
(7): 4905–4979.
129 Laughlin, S.T., Baskin, J.M., Amacher, S.L., and Bertozzi, C.R. (2008). In vivo
imaging of membrane‐associated glycans in developing zebrafish. Science 320
(5876): 664–667.
130 Xie, R., Dong, L., Huang, R. etal. (2014). Targeted imaging and proteomic analysis
of tumor‐associated glycans in living animals. Angewandte Chemie International
Edition 53 (51): 14082–14086.
131 Hong, S., Yu, C., Wang, P. etal. (2021). Glycoengineering of NK Cells with glycan
ligands of CD22 and selectins for B‐cell lymphoma therapy. Angewandte Chemie
International Edition 60 (7): 3603–3610.
132 Ge, C. and Stanley, P. (2008). The O‐fucose glycan in the ligand‐binding domain of
Notch1 regulates embryogenesis and T cell development. Proceedings of the
National Academy of Sciences of the United States of America 105 (5): 1539–1544.
133 Sung, Y.H., Baek, I.‐J., Seong, J.K. etal. (2012). Mouse genetics: catalogue and
scissors. BMB Reports 45 (12): 686–692.
134 Ioffe, E. and Stanley, P. (1994). Mice lacking N‐acetylglucosaminyltransferase I
activity die at mid‐gestation, revealing an essential role for complex or hybrid
N‐linked carbohydrates. Proceedings of the National Academy of Sciences of the
United States of America 91 (2): 728–732.
135 Metzler, M., Gertz, A., Sarkar, M. etal. (1994). Complex asparagine‐linked
oligosaccharides are required for morphogenic events during post‐implantation
development. The EMBO Journal 13 (9): 2056–2065.
136 Ye, Z. and Marth, J.D. (2004). N‐glycan branching requirement in neuronal and
postnatal viability. Glycobiology 14 (6): 547–558.
137 Shi, S., Williams, S.A., Seppo, A. etal. (2004). Inactivation of the Mgat1 gene in
oocytes impairs oogenesis, but embryos lacking complex and hybrid N‐glycans
develop and implant. Molecular and Cellular Biology 24 (22): 9920–9929.
193
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
194
138 Batista, F., Lu, L., Williams, S.A., and Stanley, P. (2012). Complex N‐glycans are
essential, but core 1 and 2mucin O‐glycans, O‐fucose glycans, and NOTCH1 are
dispensable, for mammalian spermatogenesis. Biology of Reproduction 86 (6): 179.
139 Zhou, R.W., Mkhikian, H., Grigorian, A. etal. (2014). N‐glycosylation
bidirectionally extends the boundaries of thymocyte positive selection by
2+
decoupling Lck from Ca
signaling. Nature Immunology 15 (11): 1038–1045.
140 Fonseca, K.L., Maceiras, A.R., Matos, R. etal. (2020). Deficiency in the
glycosyltransferase Gcnt1increases susceptibility to tuberculosis through a
mechanism involving neutrophils. Mucosal Immunology 13 (5): 836–848.
141 Engle, D.D., Tiriac, H., Rivera, K.D. etal. (2019). The glycan CA19‐9 promotes
pancreatitis and pancreatic cancer in mice. Science 364 (6446): 1156–1162.
142 Zavareh, R.B., Sukhai, M.A., Hurren, R. etal. (2012). Suppression of cancer
progression by MGAT1 shRNA knockdown. PLoS One 7 (9): e43721.
143 Song, Y., Aglipay, J.A., Bernstein, J.D. etal. (2010). The bisecting GlcNAc on
N‐glycans inhibits growth factor signaling and retards mammary tumor
progression. Cancer Research 70 (8): 3361–3371.
144 Silva, M.C., Fernandes, Â., Oliveira, M. etal. (2020). Glycans as immune
checkpoints: removal of branched N‐glycans enhances immune recognition
preventing cancer progression. Cancer Immunology Research 8 (11): 1407–1425.
145 Liu, F., Fu, J., Bergstrom, K. etal. (2020). Core 1–derived mucin‐type
O‐glycosylation protects against spontaneous gastritis and gastric cancer.
The Journal of Experimental Medicine 217 (1): e20182325.
146 Granovsky, M., Fata, J., Pawling, J. etal. (2000). Suppression of tumor growth and
metastasis in Mgat5‐deficient mice. Nature Medicine 6 (3): 306–312.
147 Hedlund, M., Ng, E., Varki, A., and Varki, N.M. (2008). α2‐6–linked sialic acids on
N‐glycans modulate carcinoma differentiation invivo. Cancer Research 68 (2):
388–394.
148 Magalhães, A., Gomes, J., Ismail, M.N. etal. (2009). Fut2‐null mice display an
altered glycosylation profile and impaired BabA‐mediated Helicobacter pylori
adhesion to gastric mucosa. Glycobiology 19 (12): 1525–1536.
149 Yoshida, G.J. (2020). Applications of patient‐derived tumor xenograft models and
tumor organoids. Journal of Hematology & Oncology 13 (1): 4.
150 Byrne, A.T., Alférez, D.G., Amant, F. etal. (2017). Interrogating open issues in
cancer precision medicine with patient‐derived xenografts. Nature Reviews Cancer
17 (4): 254.
151 Huang, L., Bockorny, B., Paul, I. etal. (2020). PDX‐derived organoids model
invivo drug response and secrete biomarkers. JCI Insight 5 (21): e135544.
152 Sinha, A., Hussain, A., Ignatchenko, V. etal. (2019). N‐Glycoproteomics of
patient‐derived xenografts: a strategy to discover tumor‐associated proteins in
high‐grade serous ovarian cancer. Cell Systems 8 (4): 345–51.e4.
153 Selman, M.H., Hoffmann, M., Zauner, G. etal. (2012). MALDI‐TOF‐MS analysis
of sialylated glycans and glycopeptides using 4‐chloro‐α‐cyanocinnamic acid
matrix. Proteomics 12 (9): 1337–1348.
154 Pralow, A., Cajic, S., Alagesan, K. etal. (2020). State‐of‐the‐Art Glycomics
Technologies in Glycobiotechnology, 1–33. Berlin, Heidelberg: Springer Berlin
Heidelberg.
155 Wuhrer, M. (2013). Glycomics using mass spectrometry. Glycoconjugate Journal 30
(1): 11–22.
156 Kotsias, M., Kozak, R.P., Gardner, R.A. etal. (2019). Improved and semi‐
automated reductive β‐elimination workflow for higher throughput protein
O‐glycosylation analysis. PLoS One 14 (1): e0210759.
157 Ruhaak, L., Zauner, G., Huhn, C. etal. (2010). Glycan labeling strategies and their
use in identification and quantification. Analytical and Bioanalytical Chemistry
397 (8): 3457–3481.
158 Wuhrer, M., Koeleman, C.A., Hokke, C.H., and Deelder, A.M. (2006). Mass
spectrometry of proton adducts of fucosylated N‐glycans: fucose transfer between
antennae gives rise to misleading fragments. Rapid Communications in Mass
Spectrometry: An International Journal Devoted to the Rapid Dissemination of
Up‐to‐the‐Minute Research in Mass Spectrometry 20 (11): 1747–1754.
159 de Haan, N., Reiding, K.R., Haberger, M. etal. (2015). Linkage‐specific sialic acid
derivatization for MALDI‐TOF‐MS profiling of IgG glycopeptides. Analytical
Chemistry 87 (16): 8284–8291.
160 Lageveen‐Kammeijer, G.S., de Haan, N., Mohaupt, P. etal. (2019). Highly sensitive
CE‐ESI‐MS analysis of N‐glycans from complex biological samples. Nature
Communications 10 (1): 1–8.
161 Kalay, H., Ambrosini, M., van Berkel, P.H. etal. (2012). Online nanoliquid
chromatography–mass spectrometry and nanofluorescence detection for high‐
resolution quantitative N‐glycan analysis. Analytical Biochemistry 423 (1):
153–162.
162 Hua, S., Nwosu, C.C., Strum, J.S. etal. (2012). Site‐specific protein glycosylation
analysis with glycan isomer differentiation. Analytical and Bioanalytical
Chemistry 403 (5): 1291–1302.
163 Jensen, P.H., Karlsson, N.G., Kolarich, D., and Packer, N.H. (2012). Structural
analysis of N‐ and O‐glycans released from glycoproteins. Nature Protocols 7 (7):
1299–1310.
164 Lu, G., Crihfield, C.L., Gattu, S. etal. (2018). Capillary electrophoresis separations
of glycans. Chemical Reviews 118 (17): 7867–7885.
165 Selman, M.H.J., Hemayatkar, M., Deelder, A.M., and Wuhrer, M. (2011). Cotton
HILIC SPE microtips for microscale purification and enrichment of glycans and
glycopeptides. Analytical Chemistry 83 (7): 2492–2499.
166 Jensen, P.H., Mysling, S., Højrup, P., and Jensen, O.N. (2013). Glycopeptide
Enrichment for MALDI‐TOF Mass Spectrometry Analysis by Hydrophilic Interaction
Liquid Chromatography Solid Phase Extraction (HILIC SPE). Mass Spectrometry of
Glycoproteins, 131–144. Springer.
167 Jin, C., Harvey, D.J., Struwe, W.B., and Karlsson, N.G. (2019). Separation of
isomeric O‐glycans by ion mobility and liquid chromatography–mass
spectrometry. Analytical Chemistry 91 (16): 10604–10613.
195
Соседние файлы в папке Библиотека им академика М.И. Перельмана